bgcolor="#ffffff" align="center" colspan="2" | |
align="center" colspan="2" | 17-(cyclopropylmethyl)-4,5α-epoxy- 3,14-dihydroxymorphinan-6-one |
CAS number 16676-29-2 (HCl) | ATC code ? |
| bgcolor="#eeeeee" | Chemical formula | bgcolor="#ddeeff" | C20H23NO4 |
| bgcolor="#eeeeee" | Molecular weight | bgcolor="#ddeeff" | 341.4 |
| bgcolor="#eeeeee" | Bioavailability | bgcolor="#ddeeff" | 5-40% |
| bgcolor="#eeeeee" | Metabolism | bgcolor="#ddeeff" | hepatic |
| bgcolor="#eeeeee" | Elimination half-life | bgcolor="#ddeeff" | 4 hours (naltrexone), 13 hours (6-β-naltrexol) |
| bgcolor="#eeeeee" | Excretion | bgcolor="#ddeeff" | renal |
| bgcolor="#eeeeee" | Pregnancy category | bgcolor="#ddeeff" | Category B3 (Australia) |
| bgcolor="#eeeeee" | Legal status | bgcolor="#ddeeff" | Schedule 4 (Australia) |
| bgcolor="#eeeeee" | Routes of administration | bgcolor="#ddeeff" | oral |